LBA14 Intensified alkylating chemotherapy with autologous stem cell rescue (IACT) or conventional chemotherapy followed by olaparib (CCT-O) in stage III, HER2-negative, homologous recombination deficient (HRD) breast cancer (BC): Survival results of the randomized-controlled SUBITO trial
| Autor: | Linn, S., Seefat, R.L., De Jong, V., Vliek, S.B., Balduzzi, S., Bijlsma, R.M., Jongen-Lavrencic, M., Mandjes, I., Delfos, M., Schot, M., van Rosmalen, M.M., Retel, V., Eekhout, I., Kuip, E., Gonçalves, A., Nuver, J., Wymenga, M., Konings, I.R., Tjan-Heijnen, V., Jager, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1208-S1208 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|